ResearcherJohns Hopkins UniversityActive in the last 2 years

Carter Norton

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-4991-6998; OpenAlex author ID A5058972991. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1001/jamanetworkopen.2024.53588 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Heloisa Prado Soares · 1 shared paper, 2025 · strength 0.27
- Paper KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma. DOI 10.1001/jamanetworkopen.2024.53588 ↗
Chris Nevala-Plagemann · 1 shared paper, 2025 · strength 0.27
- Paper KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma. DOI 10.1001/jamanetworkopen.2024.53588 ↗
Zach Rubnitz · 1 shared paper, 2025 · strength 0.27
- Paper KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma. DOI 10.1001/jamanetworkopen.2024.53588 ↗
Ignacio Garrido‐Laguna · 1 shared paper, 2025 · strength 0.27
- Paper KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma. DOI 10.1001/jamanetworkopen.2024.53588 ↗
Vaia Florou · 1 shared paper, 2025 · strength 0.27
- Paper KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma. DOI 10.1001/jamanetworkopen.2024.53588 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.